首页> 外文期刊>Artificial Organs >Technical Indicators to Evaluate the Degree of Large Clot Formation Inside the Membrane Fiber Bundle of an Oxygenator in an In Vitro Setup
【24h】

Technical Indicators to Evaluate the Degree of Large Clot Formation Inside the Membrane Fiber Bundle of an Oxygenator in an In Vitro Setup

机译:技术指标在体外设置中评估膜纤维束内的大凝块形成程度

获取原文
获取原文并翻译 | 示例
       

摘要

The most common technical complication during ECMO is clot formation. A large clot inside a membrane oxygenator reduces effective membrane surface area and therefore gas transfer capabilities, and restricts blood flow through the device, resulting in an increased membrane oxygenator pressure drop (dpMO). The reasons for thrombotic events are manifold and highly patient specific. Thrombus formation inside the oxygenator during ECMO is usually unpredictable and remains an unsolved problem. Clot sizes and positions are well documented in literature for the Maquet Quadrox-i Adult oxygenator based on CT data extracted from devices after patient treatment. Based on this data, the present study was designed to investigate the effects of large clots on purely technical parameters, for example, dpMO and gas transfer. Therefore, medical grade silicone was injected into the fiber bundle of the devices to replicate large clot positions and sizes. A total of six devices were tested in vitro with silicone clot volumes of 0, 30, 40, 50, 65, and 85 mL in accordance with ISO 7199. Gas transfer was measured by sampling blood pre and post device, as well as by sampling the exhaust gas at the devices' outlet at blood flow rates of 0.5, 2.5, and 5.0 L/min. Pre and post device pressure was monitored to calculate the dpMO at the different blood flow rates. The dpMO was found to be a reliable parameter to indicate a large clot only in already advanced "clotting stages." The CO2 concentration in the exhaust gas, however, was found to be sensitive to even small clot sizes and at low blood flows. Exhaust gas CO2 concentration can be monitored continuously and without any risks for the patient during ECMO therapy to provide additional information on the endurance of the oxygenator. This may help detect a clot formation and growth inside a membrane oxygenator during ECMO even if the increase in dpMO remains moderate.
机译:ECMO期间最常见的技术并发症是CLOT形成。膜内的大凝块氧管减少了有效的膜表面积,因此降低了气体转移能力,并限制通过装置的血流,导致膜氧气压降(DPMO)增加。血栓形成事件的原因是歧管和高患者的特异性。 ECMO期间氧气器内的血栓形成通常是不可预测的,仍然是未解决的问题。基于患者治疗后的器件提取的CT数据,凝块尺寸和位置在文献中为MAQUET Quadrox-I成人氧体吸附剂。基于该数据,本研究旨在探讨大凝块对纯技术参数的影响,例如DPMO和气体转移。因此,将医用级有机硅注入装置的纤维束中以复制大凝块位置和尺寸。根据ISO 7199的ISO 7199,在体外测试总共六种器件0,30,40,50,65和85ml。通过采样血液前和后装置以及采样来测量气体转移器件在血流率的出口处的废气为0.5,2.5和5.0L / min。预先监测前后装置压力以计算不同血流率的DPMO。发现DPMO是一个可靠的参数,用于仅在已经高级的“凝结阶段”中表示大型凝块。然而,已经发现废气中的CO 2浓度对甚至小凝块尺寸和低血液流动敏感。可以连续监测废气CO2浓度,并且在ECMO疗法期间没有对患者的任何风险进行监测,以提供有关氧气的耐久性的额外信息。即使DPMO的增加仍然温和,这可能有助于检测ECMO期间膜氧吸入的凝块形成和生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号